CD274 and breast carcinoma: Preclinical studies investigating the potential synergetic effects of boiling histotripsy and programmed cell death-1 receptor (PD-1) and its ligand PD-L1 pathway blockade therapy for the treatment of breast cancer are currently ongoing.